SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

COVID-19 Vaccines Confer Protection in Hospitalized Pregnant and Postpartum Women with Severe COVID-19: A Retrospective Cohort Study.

de Freitas Paganoti, C; Alkmin da Costa, R; Papageorghiou, AT; da Silva Costa, F; Quintana, SM; Graziela de Godoi, L; Adriana Jiménez Monroy, N; Sacramento Rodrigues, A; Pulcineli Vieira Francisco, R (2022) COVID-19 Vaccines Confer Protection in Hospitalized Pregnant and Postpartum Women with Severe COVID-19: A Retrospective Cohort Study. Vaccines (Basel), 10 (5). p. 749. ISSN 2076-393X https://doi.org/10.3390/vaccines10050749
SGUL Authors: Papageorghiou, Aris

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (640kB) | Preview
[img] Archive (ZIP) (Suppleemntary file 1) Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has had deleterious effects among the obstetric population. Pregnant and postpartum women constitute a high-risk group for severe COVID-19. Vaccination reduces the risk of infection, but it is not known whether women who become infected despite vaccination have a milder course of disease than those who had not been vaccinated. This retrospective cohort study evaluated whether vaccination reduces the severity of COVID-19 infection, as measured by severe maternal morbidity and mortality among hospitalized pregnant and postpartum individuals. A total of 2284 pregnant and postpartum women hospitalized with severe COVID-19 were included. Those who did and who did not receive COVID-19 vaccination were compared. The rates of intensive care unit admission, intubation, and mortality were significantly lower among subjects in the vaccinated group (p < 0.001, p < 0.001 and p < 0.001, respectively). The numbers of patients who needed to be vaccinated to avoid one case of intensive care unit admission, intubation, or death due to COVID-19 were 7, 7, and 9, respectively. The COVID-19 vaccine offers protective effects against intensive care unit admission, intubation, and death in hospitalized pregnant and postpartum women with severe SARS-CoV-2-induced SARS.

Item Type: Article
Additional Information: Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: COVID-19 vaccines, intensive care unit, intubation, maternal mortality, pregnancy, severe acute respiratory syndrome, COVID-19 vaccines, pregnancy, maternal mortality, intubation, intensive care unit, severe acute respiratory syndrome
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Vaccines (Basel)
ISSN: 2076-393X
Language: eng
Dates:
DateEvent
10 May 2022Published
9 May 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
027961Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
445881/2020-8National Council for Scientific and Technological DevelopmentUNSPECIFIED
007/2021Fundação de Amparo à Pesquisa e Inovação do Espírito Santohttp://dx.doi.org/10.13039/501100006182
PubMed ID: 35632505
Web of Science ID: WOS:000801941600001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114759
Publisher's version: https://doi.org/10.3390/vaccines10050749

Actions (login required)

Edit Item Edit Item